Stella Aslanyan
- Immunology top 5%
- Epidemiology top 10%
- Rheumatology top 5%
- Hematology top 5%
- Neurology top 10%
- Co-authors
- Christopher J. WeirKennedy R. LeesHans‐Christoph DienerMarkku KasteSteven J. PadulaSudha VisvanathanAlan M. SolingerPaul Scholl
- Topics
- Acute Ischemic Stroke Management (8 papers)Psoriasis: Treatment and Pathogenesis (4 papers)Spondyloarthritis Studies and Treatments (3 papers)
- Cited by
- ImmunologyRheumatologyHematology
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Stella Aslanyan
17 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 86
- Immunology 476
- Epidemiology 437
- Rheumatology 305
- Hematology 201
- Neurology 183
Countries citing papers authored by Stella Aslanyan
This map shows the geographic impact of Stella Aslanyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stella Aslanyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stella Aslanyan more than expected).
Fields of papers citing papers by Stella Aslanyan
This network shows the impact of papers produced by Stella Aslanyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stella Aslanyan. The network helps show where Stella Aslanyan may publish in the future.
Co-authorship network of co-authors of Stella Aslanyan
This figure shows the co-authorship network connecting the top 25 collaborators of Stella Aslanyan. A scholar is included among the top collaborators of Stella Aslanyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stella Aslanyan. Stella Aslanyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 279 | |
| 3 | 42 | |
| 4 | 2 | |
| 5 | 194 | |
| 6 | 2 | |
| 7 | HCVerso2: a phase III study of faldaprevir plus deleobuvir and ribavirin for chronic HCV genotype 1b infection in treatment naïve patients including those ineligible for pegylated interferon | 1 |
| 8 | 5 | |
| 9 | 89 | |
| 10 | 39 | |
| 11 | 36 | |
| 12 | 40 | |
| 13 | 30 | |
| 14 | 18 | |
| 15 | 259 | |
| 16 | 72 | |
| 17 | 118 |
About Stella Aslanyan
Stella Aslanyan is a scholar working on Hepatology, Rehabilitation and Rheumatology, having authored 17 papers that have together received 1.2k indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (8 papers), Psoriasis: Treatment and Pathogenesis (4 papers) and Spondyloarthritis Studies and Treatments (3 papers). The work is most often cited by research in Immunology (476 citations), Rheumatology (305 citations) and Hematology (201 citations). Stella Aslanyan has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Christopher J. Weir, Kennedy R. Lees, Hans‐Christoph Diener, Markku Kaste, Steven J. Padula, Sudha Visvanathan, Alan M. Solinger, Paul Scholl, Susanna Horner and Franz Fazekas. Their work appears in journals such as Hepatology, Clinical Infectious Diseases and Stroke.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.